US2586287A - Aluminum sulfamate antiperspirant preparation - Google Patents

Aluminum sulfamate antiperspirant preparation Download PDF

Info

Publication number
US2586287A
US2586287A US192378A US19237850A US2586287A US 2586287 A US2586287 A US 2586287A US 192378 A US192378 A US 192378A US 19237850 A US19237850 A US 19237850A US 2586287 A US2586287 A US 2586287A
Authority
US
United States
Prior art keywords
aluminum
sulfamate
discoloration
aluminum sulfamate
preparation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
US192378A
Inventor
Apperson Lester Donald
Richardson Earl Leroy
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
COLAGTE PALMOLIVE PEET Co
COLAGTE-PALMOLIVE-PEET Co
Original Assignee
COLAGTE PALMOLIVE PEET Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US64905A external-priority patent/US2586288A/en
Application filed by COLAGTE PALMOLIVE PEET Co filed Critical COLAGTE PALMOLIVE PEET Co
Priority to US192378A priority Critical patent/US2586287A/en
Application granted granted Critical
Publication of US2586287A publication Critical patent/US2586287A/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q15/00Anti-perspirants or body deodorants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A61K8/26Aluminium; Compounds thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/46Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing sulfur

Definitions

  • This invention relates to cosmetic astringent compositions and more particularly to improvements in anti-perspirant preparations.
  • the aluminum salt of sulfamic acid is a very efiicacious perspiration retardant, having been found by tests to be definitely superior to the aluminum salt of sulfuric acid in this respect; and, of more importance, it has been observed'that aluminum sulfamate is practically nontendering to clothing fabrics. Under certain severe conditions, however, aluminum sulfamate may cause some discoloration of cellulosic fibers. The discoloration appears as a yellowish to light brown cast when an aluminumsulfamate-containing preparation is japplied to and dried by heat on white fabrics made of cotton, linen or regenerated cellulosic fibers. Therefore, in order to use aluminum sulfa'mate in cosmetic preparations, it became nec- 2 essary to eliminate or reduce to a satisfactor degree its property of causing discoloration of fabrics.
  • Compounds found to aid in preventing this discoloration are as follows: Compounds which contain the functional groupECS-H and are soluble in aqueous aluminum sulfamate and which do not precipitate therefrom 'a compound containing aluminum; for example: sodium mercaptopropanesulfonate (1,2), sodium Z-mercaptoethane-l sulfonate, ammonium 2-mercaptoethane 1 sulfonate, ammonium thioglycolate, thioglycolic acid, thiourea and ethylene thiourea.
  • solubility of the substance used .as a discoloration inhibitor in the aqueous sulfamate solution may vary with the various compounds and it is essential only that a sufficient quantity of the substance used go into solution to suitably inhibit the discoloration. In some cases the substances may be present in the composition in amounts greater than the limit of solubility without disadvantage. Further, the inhibiting substance used should not reduce the anti-perspirant property of the aluminum sulfamate, nor should it cause the finished prepara- -tion to have an objectionable odor, color or other undesirable characteristics such as cause irritation.
  • test data have further indicated that aluminum sulfamate, either with or without the addition of a discoloration inhibitor from the above described groups produces definitely superior results in inhibiting perspiration when compared with like preparations which contain aluminum sulfate.
  • num sulfamate as the astringent may be used without the addition of corrosion-inhibiting agents.
  • the cosmetic or other preparation does not come in contact with cotton, muslin, rayon or the like substance whose chief ingredient is cellulose
  • the discoloration inhibitor may be omitted.
  • wool fibers do not give any discoloration when treated with solutions containing aluminum sulfamate.
  • the aluminum sulfamate-containing preparation is to be used for general purposes during which some discoloration may occur which would be objectionable, it is necessary to incorporate a suitable amount of an inhibitor such as described hereinbefore.
  • the proportion of inhibitor required to prevent discoloration varies with the particular inhibitor. In general, it has been found that it is sufiicient to employ about mol of the effective organic mercapto inhibitor for each mol of aluminum sul-famate in solution. Greater or less quantities of the discoloration inhibitor, or mixtures of different inhibitor compounds may of course be used so long as enough is incorporated to prevent discoloration where the same is objectionable.
  • novel anti-perspirant compositions containing aluminum sulfamate may be prepared and marketed in any desired form, e. g., as emulsions, suspensions, solutions, salves, creams, lotions and the like.
  • Such preparations may comprise the usual ingredients including pigments, fillers, perfumes, etc, and they may be compounded in any suitable manner.
  • acomposition should contain sufficient aluminum sulfamate to be effective when cream bases of widely varying composition either with or without a discoloration inhibitor.
  • a cream includes an oily phase held in dispersion in an aqueous phase containing the anti-perspirant by one or more suitable emulsifying agents.
  • the oily phase may include such materials as natural and synthetic oils, fats and waxes, e. g.
  • spermaceti palmityl palmitate, polymerized ethylene oxide (Carbowax), paraffin, sterols, mineral oils, vegetable oils and other esters of fatty acids, etc.
  • Carbowax polymerized ethylene oxide
  • paraffin paraffin
  • sterols paraffin
  • mineral oils mineral oils
  • vegetable oils etc.
  • Glycerine, propylene glycol, sorbitol and the like emollients may also be present.
  • Any suitable emulsifying agent may be employed which is sufiiciently stable in acid media.
  • emulsifying agents which have been found useful in preparing creams are: partial esters of fatty acids with glycerine, glycol or other polyhydric alcohol, preferably in combination with a stabilizer such as sodium monosulfate monoglyceride of coconut oil fatty acids, diethyloleylamid phosphate, sodium lauryl sulfate, sodium alkyl aromatic sulfonate, etc.
  • Example I Parts Glyceryl monostearate 13.00spermaceti wax 3.00 Stearyl alcohol 2.00 Mineral oil 1.00
  • Igepon T sodium p-oleylethane-amidsulfonate 2.50 Titanium dioxide 0.50 Aluminum sulfamate 13.00 Ammonium 2-mercaptoethane-1-sulfonate 1.64 Water 63.36
  • Example II Parts Glyceryl monostearate 15.00spermaceti wax 3.00 Mineral oil 2.00 Glycerine 2.00 Titanium dioxide 0.40 Sodium salt of sulfated m-onoglyceride of coconut oil fatty acids 3.00 Aluminum sulfamate 18.00 Sodium mercaptopropanesulfonate (12)., 2.54 Water 54.06
  • Example III Parts Acid stabilized glyceryl monostearate 13.00spermaceti wax 3.00 .
  • Stearyl alcohol 2.00 Igepon T (sodium ,B-oleylethane-amidsulfonate) 3.00
  • Aluminum sulfamate 22.50 Ammonium thioglycolate 2.34 Water 51.66
  • Acid stabilized glyceryl monostearate comprises glyceryl monostearate and a small amount (2 to o% by wt.-) of dietliyloleylamid phosphate.
  • Example IV f Parts Acid stabilized glyceryl monostearate 10.00 Glyceryl monostearate 4.00 Spermaceti wax 4.00 Mineral oil 2.00 Igepon T (sodium fi-oleylethane-amidsulfonate) 2.50; Titanium dioxide 0.50 Aluminum sulfamate 18.00 :Thioglycolic acid 1.59 Water 57.41
  • Example V Parts Glycerylmonostearate 13.0spermaceti wax' 4:.0 Glycerine -1.0
  • Glycerine 1.0 Sodium salt of sulfated monoglyceride of g coconut oil fatty acids 2.5 Titanium dioxide 10.5 Aluminum sulfamate 18.0 Thiourea 6.5 Water 52.5
  • the aluminum sulfamate cream preparations of Examples I through VI were tested to determine the efiectiveness of the various inhibitors in lessening the discoloration tendency on ifabties.
  • the cream was smeared over a cotton swatch (2" x 4" strip) until all of the fabric was covered evenly with no excess cream on the surface.
  • On thereverse side of the strip three drops of water were added to moisten the cloth, and thereafter the strip was placed in an oven and baked at about 214 F. for thirty minutes.
  • Examples of suitable aluminum sulfamate anti-perspirant solutions which may be used in liquid form or as the water phase in a cream or emulsion-type preparation, such as described in Examples I to VI, are as follows, the parts being by weight:
  • Example A Parts Aluminum sulfamate 24.9 Sodium 2-mercaptoethane-1-sulfonate 3.1 Water -1 72.0
  • Example B Parts Aluminum sulfamate 25.0 Sodium mercaptopropanesulfonate (1,2) 3.4 Water 71.6
  • Aqueous solutions of aluminum sulfamate suitable for main compounding'the anti-perspirant compositions of the invention may be prepared by any appropriate method, such as by reaction of a theoretical amount of sulfamic acid with aluminum hydroxide gel to give a clear solution of aluminum sulfamate.
  • Another method which may be used comprises the reaction of barium sulfamate in an aqueous medium with a theoretical amount of aluminum sulfate to form insoluble barium sulfate which may be removed to leave a clear solution of aluminum sulfamate.
  • a perspirant inhibiting or retarding preparation comprising an aluminum salt of sulfamic acid, in an effective amount from about 5 to about 50% by weight, said aluminum salt having a tendency to discolor cellulosic fibers, and in an amount sufiicient to inhibit said discolouration a compound which contains the functional group ECSH, said compound being soluble in aqueous aluminum sulfamate and not precipitating therefrom a compound containing aluminum.
  • a perspirant inhibiting or retarding preparation in the form of a cream comprising fatty material emulsified with a water-containing phase, an efiective amount of aluminum sulfamate from about 5 to about 50% by weight, said aluminum sulfamate having a tendency to discolor cellulosic fibers, and in an amount suflicient to inhibit said discoloration a compound having the functional group EC-SH which is soluble in aqueous aluminum sulfamate and does not precipitate a compound containing aluminum.
  • a perspirant inhibiting or retarding preparation comprising a water-containing vehicle, aluminum sulfamate in an effective amount from about 5 to about 50% by weight, said aluminum sulfamate having a tendency to discolor cellulosic fibers, and sodium 2-mercaptoethane-1- sulfonate in an amount sufficient to inhibit said discoloration.
  • a perspirant inhibiting or retarding preparation comprising a water-containing vehicle
  • aluminum sulfamate in an effective amount from about to about 50% by weight, said aluminum sulfamate having .a tendency to discolor cellulosic fibers, and ammonium 2-mercaptoethanel-sulfonate in an amount suihcient to inhibit said discoloration.
  • a perspirant inhibiting or retarding preparation comprising a water-containing vehicle, aluminum sulfamate in an effective amount from about 5 to about 50% by weight, said aluminum sulfamate having a tendency to discolor cellulosic fibers, and ammonium thioglycolate in an amount suflicient to inhibit said discoloration.
  • a cosmetic preparation for inhibiting or retarding perspiration comprising an emulsion of an oleaginous phase and an aqueous phase, and
  • fective amount from about 5 to about 50% by Weight to inhibit perspiration upon application of said preparation to human skin.
  • a cosmetic preparation in the form of a cream emulsion for inhibiting or retarding perspiration comprising a cream emulsion of an oleaginous phase held in dispersion in an aqueous phase, an acid stable emulsifying agent therefor to 'maintainsaid emulsion, and as an essential anti-perspirant ingredient aluminum sulfamate in an eifective amount from about 5 to about by weight in solution in said aqueous phase.

Description

Patented Feb. 19, 1952 ALUIHIN UM SULFAMATE ANTIPERSPIRANT PREPARATION Lester Donald Apperson, Convent Station, and
Earl Leroy Richardson, Fair Lawn, N. J., assignors to Colgate-Palmolive-Peet Company, Jersey City, N. J a corporation of Delaware No Drawing. Original application December 11,
1948, Serial No. 64,905. Divided and this application October 26, 1950, Serial No. 192,378
7 Claims. 1
This invention relates to cosmetic astringent compositions and more particularly to improvements in anti-perspirant preparations.
Among the many anti-perspirants described as having the property of retarding or inhibiting the flow of perspiration the most efiective have been found heretofore to be those containing aluminum salts of strong inorganic acids, e. g. hydrochloric, sulfuric, etc. Cosmetic preparations containing salts of these strong acids, however, have the very serious disadvantage of corroding or tendering clothing fabric, e. g. portions of garments which come in contact with areas of the body on which the preparation is applied. This corrosive action is especially noticeable on fabrics containing cellulosicmaterials such as cotton, rayon and the like. The corrosive effect that is detrimental to fabrics manifests itself particularly where the clothing portion carrying some of the anti-perspirant material is ironed or otherwise subjected to a relatively high temperature before removal of the anti-perspirant preparation. Even long continued contact at ordinary temperatures of cosmetic preparations contain ing aluminum salts of these mineral acids cause weakening or deterioration of the clothing fabric. Of the many salts which have been used or described as useful anti-prespirants, aluminum chloride and aluminium sulfate are by far the most commonly used and have heretofore been considered to be the most effective. However, .both salts show high corrosive action on cotton fabrics, This corrosive action is so severe that considerable research and investigation has been directed to a satisfactory reduction of the corrosive action without simultaneously reducing the anti-perspirant effectiveness of the salts. Because- ,of its less-corrosive action, aluminum sulfate is generally preferred over aluminum chloride.
It has been discovered that the aluminum salt of sulfamic acid is a very efiicacious perspiration retardant, having been found by tests to be definitely superior to the aluminum salt of sulfuric acid in this respect; and, of more importance, it has been observed'that aluminum sulfamate is practically nontendering to clothing fabrics. Under certain severe conditions, however, aluminum sulfamate may cause some discoloration of cellulosic fibers. The discoloration appears as a yellowish to light brown cast when an aluminumsulfamate-containing preparation is japplied to and dried by heat on white fabrics made of cotton, linen or regenerated cellulosic fibers. Therefore, in order to use aluminum sulfa'mate in cosmetic preparations, it became nec- 2 essary to eliminate or reduce to a satisfactor degree its property of causing discoloration of fabrics.
Extensive research was carried out with the object of finding a way to overcome this undesirable discoloration elfect without impairing the efficiency of the aluminum sulfamate as an anti-perspirant. It was discovered that the discoloration tendency could be prevented or satisfactorily lessened by incorporating in the antiperspirant preparation certain organic compounds in sufficient concentration. Compounds found to aid in preventing this discoloration are as follows: Compounds which contain the functional groupECS-H and are soluble in aqueous aluminum sulfamate and which do not precipitate therefrom 'a compound containing aluminum; for example: sodium mercaptopropanesulfonate (1,2), sodium Z-mercaptoethane-l sulfonate, ammonium 2-mercaptoethane 1 sulfonate, ammonium thioglycolate, thioglycolic acid, thiourea and ethylene thiourea.
The extent of solubility of the substance used .as a discoloration inhibitor in the aqueous sulfamate solution may vary with the various compounds and it is essential only that a sufficient quantity of the substance used go into solution to suitably inhibit the discoloration. In some cases the substances may be present in the composition in amounts greater than the limit of solubility without disadvantage. Further, the inhibiting substance used should not reduce the anti-perspirant property of the aluminum sulfamate, nor should it cause the finished prepara- -tion to have an objectionable odor, color or other undesirable characteristics such as cause irritation.
It is, of course, recognized that a few of the compounds listed above and many others which are inoperative in the present invention have been proposed for use in anti-perspirant preparations containing aluminum chloride or aluminum sulfate to prevent serious weakening or the destruotion of fabric due to the corrosive action of these salts. In such preparations, however, the problem was soley to prevent tendering of the fabric since aluminum chloride and sulfate cause no discoloration and there was no reason to suggest that any known anti-tendering agentwould be useful in preparations employing aluminum sulfamate for the entirely different function of preventing discoloration, particularly since tests had demonstrated that no anti-tendering agent was necessary in aluminum sulfamate preparations, nor was there anything to guide the search for anti-discoloring agents.
Test data have further indicated that aluminum sulfamate, either with or without the addition of a discoloration inhibitor from the above described groups produces definitely superior results in inhibiting perspiration when compared with like preparations which contain aluminum sulfate.
To secure such data, specific areas of skin of a number of human subjects were treated daily over a definite period and the perspiration inhibiting eifects for aluminum sulfate and aluminum sulfamate were evaluated. The perspiration from two equal, comparable areas of skin with and without anti-perspirant treatment was periodically collected and weighed. For each measurement a percent of perspiration-lessening effect was calculated as follows: Where X: weight of perspiration on untreated area and Y weight of perspiration on like area treated with anti-perspirant material, then, the perspiration-lessening effect, as represented by (Z), expressed in percent, is as follows:
num sulfamate as the astringent may be used without the addition of corrosion-inhibiting agents. Furthermore, where the cosmetic or other preparation does not come in contact with cotton, muslin, rayon or the like substance whose chief ingredient is cellulose, the discoloration inhibitor may be omitted. For example, wool fibers do not give any discoloration when treated with solutions containing aluminum sulfamate. Where, however, the aluminum sulfamate-containing preparation is to be used for general purposes during which some discoloration may occur which would be objectionable, it is necessary to incorporate a suitable amount of an inhibitor such as described hereinbefore.
The proportion of inhibitor required to prevent discoloration varies with the particular inhibitor. In general, it has been found that it is sufiicient to employ about mol of the effective organic mercapto inhibitor for each mol of aluminum sul-famate in solution. Greater or less quantities of the discoloration inhibitor, or mixtures of different inhibitor compounds may of course be used so long as enough is incorporated to prevent discoloration where the same is objectionable.
In accordance with the present invention, novel anti-perspirant compositions containing aluminum sulfamate may be prepared and marketed in any desired form, e. g., as emulsions, suspensions, solutions, salves, creams, lotions and the like. Such preparations may comprise the usual ingredients including pigments, fillers, perfumes, etc, and they may be compounded in any suitable manner.
The proportion of aluminum sulfamate antiperspirant ingredient to the total composition may be rather widely varied and depends to some extent upon the particular type of preparation, frequency of use, and other variable factors. In general, acomposition should contain sufficient aluminum sulfamate to be effective when cream bases of widely varying composition either with or without a discoloration inhibitor. Generally speaking, such a cream includes an oily phase held in dispersion in an aqueous phase containing the anti-perspirant by one or more suitable emulsifying agents. The oily phase may include such materials as natural and synthetic oils, fats and waxes, e. g. spermaceti, palmityl palmitate, polymerized ethylene oxide (Carbowax), paraffin, sterols, mineral oils, vegetable oils and other esters of fatty acids, etc. Glycerine, propylene glycol, sorbitol and the like emollients may also be present.
Any suitable emulsifying agent may be employed which is sufiiciently stable in acid media.
Examples of emulsifying agents which have been found useful in preparing creams are: partial esters of fatty acids with glycerine, glycol or other polyhydric alcohol, preferably in combination with a stabilizer such as sodium monosulfate monoglyceride of coconut oil fatty acids, diethyloleylamid phosphate, sodium lauryl sulfate, sodium alkyl aromatic sulfonate, etc.
As specific examples of preparations embodying the principles of this invention the following are given without intending to be limited thereby. The parts indicated are by weight.
Example I Parts Glyceryl monostearate 13.00 Spermaceti wax 3.00 Stearyl alcohol 2.00 Mineral oil 1.00
Igepon T (sodium p-oleylethane-amidsulfonate) 2.50 Titanium dioxide 0.50 Aluminum sulfamate 13.00 Ammonium 2-mercaptoethane-1-sulfonate 1.64 Water 63.36
Example II Parts Glyceryl monostearate 15.00 Spermaceti wax 3.00 Mineral oil 2.00 Glycerine 2.00 Titanium dioxide 0.40 Sodium salt of sulfated m-onoglyceride of coconut oil fatty acids 3.00 Aluminum sulfamate 18.00 Sodium mercaptopropanesulfonate (12)., 2.54 Water 54.06
Example III Parts Acid stabilized glyceryl monostearate 13.00 Spermaceti wax 3.00 .Stearyl alcohol 2.00 Igepon T (sodium ,B-oleylethane-amidsulfonate) 3.00 Glycerine 2.50 Aluminum sulfamate 22.50 Ammonium thioglycolate 2.34 Water 51.66
1 Acid stabilized glyceryl monostearate" comprises glyceryl monostearate and a small amount (2 to o% by wt.-) of dietliyloleylamid phosphate.
5, Example IV f Parts Acid stabilized glyceryl monostearate 10.00 Glyceryl monostearate 4.00 Spermaceti wax 4.00 Mineral oil 2.00 Igepon T (sodium fi-oleylethane-amidsulfonate) 2.50; Titanium dioxide 0.50 Aluminum sulfamate 18.00 :Thioglycolic acid 1.59 Water 57.41
" Example V Parts Glycerylmonostearate 13.0 Spermaceti wax' 4:.0 Glycerine -1.0
Sodium salt of sulfated monoglyceride of coconut oil fatty acids 2.3 Titanium dioxide 0.3 Aluminum sulfamate 20.0 Ethylene thiourea 1.6 Water 57.8
Example VI I Parts Diethylene glycol monostearate 16.0
Palmityl palmitate 3.0
Glycerine 1.0 Sodium salt of sulfated monoglyceride of g coconut oil fatty acids 2.5 Titanium dioxide 10.5 Aluminum sulfamate 18.0 Thiourea 6.5 Water 52.5
The aluminum sulfamate cream preparations of Examples I through VI were tested to determine the efiectiveness of the various inhibitors in lessening the discoloration tendency on ifabties. In carrying out the tests the cream was smeared over a cotton swatch (2" x 4" strip) until all of the fabric was covered evenly with no excess cream on the surface. On thereverse side of the strip three drops of water were added to moisten the cloth, and thereafter the strip was placed in an oven and baked at about 214 F. for thirty minutes. These swatches were tested alongside a cotton swatch smeared with a like aluminum sulfamate cream preparation which contained no discoloration Even under the severe conditions of this test, the strip treated with the uninhibited cream was discolored to a greater extent than any of the strips treated with creams of Examples I to VI, and in the case of Examples I, II, IV andVI, there was practically no discoloration. Further, it has been ascertained from tests of the cream containing the inhibitor giving the least eiiect under the severe conditions of the above test that even this substance was efiective in inhibiting this undesirable coloring efiect on fabric when tested under conditions comparable to those'encountered during the normal use of the antiperspirant.
Examples of suitable aluminum sulfamate anti-perspirant solutions which may be used in liquid form or as the water phase in a cream or emulsion-type preparation, such as described in Examples I to VI, are as follows, the parts being by weight:
Example A Parts Aluminum sulfamate 24.9 Sodium 2-mercaptoethane-1-sulfonate 3.1 Water -1 72.0
inhibitor.
a the swatches dipped in Example B Parts Aluminum sulfamate 25.0 Sodium mercaptopropanesulfonate (1,2) 3.4 Water 71.6
Example (I Parts Aluminum sulfamate 24.9 Thiourea 6.0 Water 69.1
The effectiveness of the various discoloration inhibitors in Examples A, B and C were tested'by dipping a cotton swatch into each solution and heating in an oven at about 214 F. for thirty minutes. In each case the discoloration of a similarly treated swatch which had been dipped into a solution of aluminum sulfamate containing no inhibitor was much greater than any of the solutions 01 Examples A,'B, and C.
Aqueous solutions of aluminum sulfamate suitable for main compounding'the anti-perspirant compositions of the invention may be prepared by any appropriate method, such as by reaction of a theoretical amount of sulfamic acid with aluminum hydroxide gel to give a clear solution of aluminum sulfamate. Another method which may be used comprises the reaction of barium sulfamate in an aqueous medium with a theoretical amount of aluminum sulfate to form insoluble barium sulfate which may be removed to leave a clear solution of aluminum sulfamate.
Although the invention has been described in detail and exemplified by numerous examples, it will be understood that the principles of the invention may be made use of by utilizing aluminum sulfamate with modified formulae such as will occur to those skilled in the art.
The present application is a division of patent application Serial Number 64,905, filed December 11, 1948.
Having described the invention what is desired to be secured by Letters Patent is: a
1. A perspirant inhibiting or retarding preparation comprising an aluminum salt of sulfamic acid, in an effective amount from about 5 to about 50% by weight, said aluminum salt having a tendency to discolor cellulosic fibers, and in an amount sufiicient to inhibit said discolouration a compound which contains the functional group ECSH, said compound being soluble in aqueous aluminum sulfamate and not precipitating therefrom a compound containing aluminum.
2. A perspirant inhibiting or retarding preparation in the form of a cream comprising fatty material emulsified with a water-containing phase, an efiective amount of aluminum sulfamate from about 5 to about 50% by weight, said aluminum sulfamate having a tendency to discolor cellulosic fibers, and in an amount suflicient to inhibit said discoloration a compound having the functional group EC-SH which is soluble in aqueous aluminum sulfamate and does not precipitate a compound containing aluminum.
3. A perspirant inhibiting or retarding preparation comprising a water-containing vehicle, aluminum sulfamate in an effective amount from about 5 to about 50% by weight, said aluminum sulfamate having a tendency to discolor cellulosic fibers, and sodium 2-mercaptoethane-1- sulfonate in an amount sufficient to inhibit said discoloration.
4. A perspirant inhibiting or retarding preparation comprising a water-containing vehicle,
7 aluminum sulfamate in an effective amount from about to about 50% by weight, said aluminum sulfamate having .a tendency to discolor cellulosic fibers, and ammonium 2-mercaptoethanel-sulfonate in an amount suihcient to inhibit said discoloration.
5. A perspirant inhibiting or retarding preparation comprising a water-containing vehicle, aluminum sulfamate in an effective amount from about 5 to about 50% by weight, said aluminum sulfamate having a tendency to discolor cellulosic fibers, and ammonium thioglycolate in an amount suflicient to inhibit said discoloration.
6. A cosmetic preparation for inhibiting or retarding perspiration comprising an emulsion of an oleaginous phase and an aqueous phase, and
"including therein aluminum sulfamate in an ef-:-
fective amount from about 5 to about 50% by Weight to inhibit perspiration upon application of said preparation to human skin.
'7. A cosmetic preparation in the form of a cream emulsion for inhibiting or retarding perspiration comprising a cream emulsion of an oleaginous phase held in dispersion in an aqueous phase, an acid stable emulsifying agent therefor to 'maintainsaid emulsion, and as an essential anti-perspirant ingredient aluminum sulfamate in an eifective amount from about 5 to about by weight in solution in said aqueous phase.
LESTER DONALD APPERSON EARL LEROY RICHARDSON.
REFERENCES CITED The following references are of record in the file of this patent:
UNITED STATES PATENTS OTHER REFERENCES Oberhauser: Chemical Abstracts, vol. 41, April 10, 1947, page 1944. i

Claims (1)

  1. 6. A COSMETIC PREPARATION FOR INHIBITING OR RETARADING PERSPIRATION COMPRISING AN EMULSION OF AN OLEAGINOUS PHASE AND AN AQUEOUS PHASE, AND INCLUDING THEREIN ALUMINUM SULFAMATE IN AN EFFECTIVE AMOUNT FROM ABOUT 5 TO ABOUT 50% BY WEIGHT TO INHIBIT PERSPIRATION UPON APPLICATION OF SAID PREPARATION TO HUMAN SKIN.
US192378A 1948-12-11 1950-10-26 Aluminum sulfamate antiperspirant preparation Expired - Lifetime US2586287A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
US192378A US2586287A (en) 1948-12-11 1950-10-26 Aluminum sulfamate antiperspirant preparation

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US64905A US2586288A (en) 1948-12-11 1948-12-11 Aluminum sulfamate antiperspirant
US192378A US2586287A (en) 1948-12-11 1950-10-26 Aluminum sulfamate antiperspirant preparation

Publications (1)

Publication Number Publication Date
US2586287A true US2586287A (en) 1952-02-19

Family

ID=26745023

Family Applications (1)

Application Number Title Priority Date Filing Date
US192378A Expired - Lifetime US2586287A (en) 1948-12-11 1950-10-26 Aluminum sulfamate antiperspirant preparation

Country Status (1)

Country Link
US (1) US2586287A (en)

Cited By (50)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2783181A (en) * 1953-03-18 1957-02-26 Colgate Palmolive Co Stabilized antiperspirant cosmetic cream
US4010252A (en) * 1974-12-19 1977-03-01 Colgate-Palmolive Company Antimicrobial compositions
US5518714A (en) * 1984-04-24 1996-05-21 Chesebrough-Pond's Usa Co., Division Of Conopco, Inc. Method for inhibiting the dissolution of antiperspirant compounds in alcohols
US20050186147A1 (en) * 2004-02-04 2005-08-25 Foamix Ltd. Cosmetic and pharmaceutical foam with solid matter
US20050186142A1 (en) * 2002-10-25 2005-08-25 Foamix Ltd. Kit and composition of imidazole with enhanced bioavailability
US20050205086A1 (en) * 2002-10-25 2005-09-22 Foamix Ltd. Retinoid immunomodulating kit and composition and uses thereof
US20050244342A1 (en) * 2002-10-25 2005-11-03 Foamix Ltd. Moisturizing foam containing lanolin
US20050271596A1 (en) * 2002-10-25 2005-12-08 Foamix Ltd. Vasoactive kit and composition and uses thereof
US20060018937A1 (en) * 2002-10-25 2006-01-26 Foamix Ltd. Steroid kit and foamable composition and uses thereof
US20060140984A1 (en) * 2002-10-25 2006-06-29 Foamix Ltd. Cosmetic and pharmaceutical foam
US20060193789A1 (en) * 2002-10-25 2006-08-31 Foamix Ltd. Film forming foamable composition
US20060233721A1 (en) * 2002-10-25 2006-10-19 Foamix Ltd. Foam containing unique oil globules
US20060275218A1 (en) * 2003-08-04 2006-12-07 Foamix Ltd. Foamable vehicle and pharmaceutical compositions thereof
US20070253911A1 (en) * 2002-10-25 2007-11-01 Foamix Ltd. Foamable compositions, kits and methods for hyperhidrosis
US20070280891A1 (en) * 2003-08-04 2007-12-06 Foamix Ltd. Oleaginous pharmaceutical and cosmetic foam
US20070292355A1 (en) * 2002-10-25 2007-12-20 Foamix Ltd. Anti-infection augmentation foamable compositions and kit and uses thereof
US20070292359A1 (en) * 2002-10-25 2007-12-20 Foamix Ltd. Polypropylene glycol foamable vehicle and pharmaceutical compositions thereof
US20080044444A1 (en) * 2002-10-25 2008-02-21 Foamix Ltd. Dicarboxylic acid foamable vehicle and pharmaceutical compositions thereof
US20080152596A1 (en) * 2005-07-19 2008-06-26 Foamix Ltd. Polypropylene glycol foamable vehicle and pharmaceutical compositions thereof
US20080166303A1 (en) * 2006-09-08 2008-07-10 Dov Tamarkin Colored or colorable foamable composition and foam
US20080206155A1 (en) * 2006-11-14 2008-08-28 Foamix Ltd. Stable non-alcoholic foamable pharmaceutical emulsion compositions with an unctuous emollient and their uses
US20080206161A1 (en) * 2002-10-25 2008-08-28 Dov Tamarkin Quiescent foamable compositions, steroids, kits and uses thereof
US20080206159A1 (en) * 2003-08-04 2008-08-28 Foamix Ltd. Compositions with modulating agents
US20080253973A1 (en) * 2002-10-25 2008-10-16 Foamix Ltd. Sensation modifying topical composition foam
US20080260655A1 (en) * 2006-11-14 2008-10-23 Dov Tamarkin Substantially non-aqueous foamable petrolatum based pharmaceutical and cosmetic compositions and their uses
US20080292560A1 (en) * 2007-01-12 2008-11-27 Dov Tamarkin Silicone in glycol pharmaceutical and cosmetic compositions with accommodating agent
US20080299220A1 (en) * 2003-08-04 2008-12-04 Dov Tamarkin Hydrophilic, non-aqueous pharmaceutical carriers and compositions and uses
US20080317679A1 (en) * 2002-10-25 2008-12-25 Foamix Ltd. Foamable compositions and kits comprising one or more of a channel agent, a cholinergic agent, a nitric oxide donor, and related agents and their uses
US20090130029A1 (en) * 2007-11-21 2009-05-21 Foamix Ltd. Glycerol ethers vehicle and pharmaceutical compositions thereof
US20090180970A1 (en) * 2002-10-25 2009-07-16 Foamix Ltd. Foamable composition combining a polar solvent and a hydrophobic carrier
US7575739B2 (en) 2003-04-28 2009-08-18 Foamix Ltd. Foamable iodine composition
US20100284938A1 (en) * 2002-10-25 2010-11-11 Foamix Ltd. Penetrating pharmaceutical foam
US20100310476A1 (en) * 2007-12-07 2010-12-09 Foamix Ltd. Carriers, formulations, methods for formulating unstable active agents for external application and uses thereof
US20110008266A1 (en) * 2008-01-14 2011-01-13 Foamix Ltd. Poloxamer foamable pharmaceutical compositions with active agents and/or therapeutic cells and uses
US20110045037A1 (en) * 2007-11-30 2011-02-24 Foamix Ltd. Foam containing benzoyl peroxide
US20110178162A1 (en) * 2005-10-14 2011-07-21 Medical University Of South Carolina Targeting pax2 for the induction of defb1-mediated tumor immunity and cancer therapy
US8119150B2 (en) 2002-10-25 2012-02-21 Foamix Ltd. Non-flammable insecticide composition and uses thereof
US8512718B2 (en) 2000-07-03 2013-08-20 Foamix Ltd. Pharmaceutical composition for topical application
US8518376B2 (en) 2007-12-07 2013-08-27 Foamix Ltd. Oil-based foamable carriers and formulations
US8618081B2 (en) 2009-10-02 2013-12-31 Foamix Ltd. Compositions, gels and foams with rheology modulators and uses thereof
US8636982B2 (en) 2007-08-07 2014-01-28 Foamix Ltd. Wax foamable vehicle and pharmaceutical compositions thereof
US8900554B2 (en) 2002-10-25 2014-12-02 Foamix Pharmaceuticals Ltd. Foamable composition and uses thereof
US9072667B2 (en) 2009-07-29 2015-07-07 Foamix Pharmaceuticals Ltd. Non surface active agent non polymeric agent hydro-alcoholic foamable compositions, breakable foams and their uses
US9167813B2 (en) 2009-07-29 2015-10-27 Foamix Pharmaceuticals Ltd. Non surfactant hydro-alcoholic foamable compositions, breakable foams and their uses
US9211259B2 (en) 2002-11-29 2015-12-15 Foamix Pharmaceuticals Ltd. Antibiotic kit and composition and uses thereof
US9539208B2 (en) 2002-10-25 2017-01-10 Foamix Pharmaceuticals Ltd. Foam prepared from nanoemulsions and uses
US9668972B2 (en) 2002-10-25 2017-06-06 Foamix Pharmaceuticals Ltd. Nonsteroidal immunomodulating kit and composition and uses thereof
US9849142B2 (en) 2009-10-02 2017-12-26 Foamix Pharmaceuticals Ltd. Methods for accelerated return of skin integrity and for the treatment of impetigo
US9884017B2 (en) 2009-04-28 2018-02-06 Foamix Pharmaceuticals Ltd. Foamable vehicles and pharmaceutical compositions comprising aprotic polar solvents and uses thereof
US10398641B2 (en) 2016-09-08 2019-09-03 Foamix Pharmaceuticals Ltd. Compositions and methods for treating rosacea and acne

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US1621528A (en) * 1921-09-21 1927-03-22 Ellis Carleton Composition of matter for treating animal tissue
US2165870A (en) * 1938-04-07 1939-07-11 Du Pont Production of leather
US2236387A (en) * 1938-05-03 1941-03-25 Wallace Jr Perspiration inhibiting composition
US2504107A (en) * 1946-10-04 1950-04-18 Purdue Research Foundation Aluminum methionate

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US1621528A (en) * 1921-09-21 1927-03-22 Ellis Carleton Composition of matter for treating animal tissue
US2165870A (en) * 1938-04-07 1939-07-11 Du Pont Production of leather
US2236387A (en) * 1938-05-03 1941-03-25 Wallace Jr Perspiration inhibiting composition
US2504107A (en) * 1946-10-04 1950-04-18 Purdue Research Foundation Aluminum methionate

Cited By (126)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2783181A (en) * 1953-03-18 1957-02-26 Colgate Palmolive Co Stabilized antiperspirant cosmetic cream
US4010252A (en) * 1974-12-19 1977-03-01 Colgate-Palmolive Company Antimicrobial compositions
US5518714A (en) * 1984-04-24 1996-05-21 Chesebrough-Pond's Usa Co., Division Of Conopco, Inc. Method for inhibiting the dissolution of antiperspirant compounds in alcohols
US8512718B2 (en) 2000-07-03 2013-08-20 Foamix Ltd. Pharmaceutical composition for topical application
US20080138293A1 (en) * 2002-10-24 2008-06-12 Foamix Ltd Cosmetic and pharmaceutical foam
US9713643B2 (en) 2002-10-25 2017-07-25 Foamix Pharmaceuticals Ltd. Foamable carriers
US20080253973A1 (en) * 2002-10-25 2008-10-16 Foamix Ltd. Sensation modifying topical composition foam
US20050271596A1 (en) * 2002-10-25 2005-12-08 Foamix Ltd. Vasoactive kit and composition and uses thereof
US20060018937A1 (en) * 2002-10-25 2006-01-26 Foamix Ltd. Steroid kit and foamable composition and uses thereof
US20060140984A1 (en) * 2002-10-25 2006-06-29 Foamix Ltd. Cosmetic and pharmaceutical foam
US20060193789A1 (en) * 2002-10-25 2006-08-31 Foamix Ltd. Film forming foamable composition
US20060233721A1 (en) * 2002-10-25 2006-10-19 Foamix Ltd. Foam containing unique oil globules
US10821077B2 (en) 2002-10-25 2020-11-03 Foamix Pharmaceuticals Ltd. Dicarboxylic acid foamable vehicle and pharmaceutical compositions thereof
US20070253911A1 (en) * 2002-10-25 2007-11-01 Foamix Ltd. Foamable compositions, kits and methods for hyperhidrosis
US10322085B2 (en) 2002-10-25 2019-06-18 Foamix Pharmaceuticals Ltd. Dicarboxylic acid foamable vehicle and pharmaceutical compositions thereof
US20070292355A1 (en) * 2002-10-25 2007-12-20 Foamix Ltd. Anti-infection augmentation foamable compositions and kit and uses thereof
US20070292359A1 (en) * 2002-10-25 2007-12-20 Foamix Ltd. Polypropylene glycol foamable vehicle and pharmaceutical compositions thereof
US20080044444A1 (en) * 2002-10-25 2008-02-21 Foamix Ltd. Dicarboxylic acid foamable vehicle and pharmaceutical compositions thereof
US20050205086A1 (en) * 2002-10-25 2005-09-22 Foamix Ltd. Retinoid immunomodulating kit and composition and uses thereof
US10117812B2 (en) 2002-10-25 2018-11-06 Foamix Pharmaceuticals Ltd. Foamable composition combining a polar solvent and a hydrophobic carrier
US8119150B2 (en) 2002-10-25 2012-02-21 Foamix Ltd. Non-flammable insecticide composition and uses thereof
US9668972B2 (en) 2002-10-25 2017-06-06 Foamix Pharmaceuticals Ltd. Nonsteroidal immunomodulating kit and composition and uses thereof
US20080206161A1 (en) * 2002-10-25 2008-08-28 Dov Tamarkin Quiescent foamable compositions, steroids, kits and uses thereof
US9622947B2 (en) 2002-10-25 2017-04-18 Foamix Pharmaceuticals Ltd. Foamable composition combining a polar solvent and a hydrophobic carrier
US20050244342A1 (en) * 2002-10-25 2005-11-03 Foamix Ltd. Moisturizing foam containing lanolin
US9539208B2 (en) 2002-10-25 2017-01-10 Foamix Pharmaceuticals Ltd. Foam prepared from nanoemulsions and uses
US9492412B2 (en) 2002-10-25 2016-11-15 Foamix Pharmaceuticals Ltd. Penetrating pharmaceutical foam
US9320705B2 (en) 2002-10-25 2016-04-26 Foamix Pharmaceuticals Ltd. Sensation modifying topical composition foam
US20080317679A1 (en) * 2002-10-25 2008-12-25 Foamix Ltd. Foamable compositions and kits comprising one or more of a channel agent, a cholinergic agent, a nitric oxide donor, and related agents and their uses
US9265725B2 (en) 2002-10-25 2016-02-23 Foamix Pharmaceuticals Ltd. Dicarboxylic acid foamable vehicle and pharmaceutical compositions thereof
US8119109B2 (en) 2002-10-25 2012-02-21 Foamix Ltd. Foamable compositions, kits and methods for hyperhidrosis
US20090180970A1 (en) * 2002-10-25 2009-07-16 Foamix Ltd. Foamable composition combining a polar solvent and a hydrophobic carrier
US20050186142A1 (en) * 2002-10-25 2005-08-25 Foamix Ltd. Kit and composition of imidazole with enhanced bioavailability
US8900554B2 (en) 2002-10-25 2014-12-02 Foamix Pharmaceuticals Ltd. Foamable composition and uses thereof
US8840869B2 (en) 2002-10-25 2014-09-23 Foamix Ltd. Body cavity foams
US8741265B2 (en) 2002-10-25 2014-06-03 Foamix Ltd. Penetrating pharmaceutical foam
US8722021B2 (en) 2002-10-25 2014-05-13 Foamix Ltd. Foamable carriers
US20100284938A1 (en) * 2002-10-25 2010-11-11 Foamix Ltd. Penetrating pharmaceutical foam
US11033491B2 (en) 2002-10-25 2021-06-15 Vyne Therapeutics Inc. Dicarboxylic acid foamable vehicle and pharmaceutical compositions thereof
US8486376B2 (en) 2002-10-25 2013-07-16 Foamix Ltd. Moisturizing foam containing lanolin
US8435498B2 (en) 2002-10-25 2013-05-07 Foamix Ltd. Penetrating pharmaceutical foam
US9211259B2 (en) 2002-11-29 2015-12-15 Foamix Pharmaceuticals Ltd. Antibiotic kit and composition and uses thereof
US7575739B2 (en) 2003-04-28 2009-08-18 Foamix Ltd. Foamable iodine composition
US8119106B2 (en) 2003-04-28 2012-02-21 Foamix Ltd Foamable iodine compositions
US8486375B2 (en) 2003-04-28 2013-07-16 Foamix Ltd. Foamable compositions
US20080206159A1 (en) * 2003-08-04 2008-08-28 Foamix Ltd. Compositions with modulating agents
US8486374B2 (en) 2003-08-04 2013-07-16 Foamix Ltd. Hydrophilic, non-aqueous pharmaceutical carriers and compositions and uses
US8518378B2 (en) 2003-08-04 2013-08-27 Foamix Ltd. Oleaginous pharmaceutical and cosmetic foam
US20060275218A1 (en) * 2003-08-04 2006-12-07 Foamix Ltd. Foamable vehicle and pharmaceutical compositions thereof
US20070280891A1 (en) * 2003-08-04 2007-12-06 Foamix Ltd. Oleaginous pharmaceutical and cosmetic foam
US8362091B2 (en) 2003-08-04 2013-01-29 Foamix Ltd. Foamable vehicle and pharmaceutical compositions thereof
US8114385B2 (en) 2003-08-04 2012-02-14 Foamix Ltd. Oleaginous pharmaceutical and cosmetic foam
US7820145B2 (en) 2003-08-04 2010-10-26 Foamix Ltd. Oleaginous pharmaceutical and cosmetic foam
US9050253B2 (en) 2003-08-04 2015-06-09 Foamix Pharmaceuticals Ltd. Oleaginous pharmaceutical and cosmetic foam
US20100266510A1 (en) * 2003-08-04 2010-10-21 Foamix Ltd. Foamable Vehicle and Pharmaceutical Compositions Thereof
US20080299220A1 (en) * 2003-08-04 2008-12-04 Dov Tamarkin Hydrophilic, non-aqueous pharmaceutical carriers and compositions and uses
US9101662B2 (en) 2003-08-04 2015-08-11 Foamix Pharmaceuticals Ltd. Compositions with modulating agents
US20110002857A1 (en) * 2003-08-04 2011-01-06 Foamix Ltd. Oleaginous pharmaceutical and cosmetic foam
US8795693B2 (en) 2003-08-04 2014-08-05 Foamix Ltd. Compositions with modulating agents
US9636405B2 (en) 2003-08-04 2017-05-02 Foamix Pharmaceuticals Ltd. Foamable vehicle and pharmaceutical compositions thereof
US8703105B2 (en) 2003-08-04 2014-04-22 Foamix Ltd. Oleaginous pharmaceutical and cosmetic foam
US7704518B2 (en) 2003-08-04 2010-04-27 Foamix, Ltd. Foamable vehicle and pharmaceutical compositions thereof
US20050186147A1 (en) * 2004-02-04 2005-08-25 Foamix Ltd. Cosmetic and pharmaceutical foam with solid matter
US20080152596A1 (en) * 2005-07-19 2008-06-26 Foamix Ltd. Polypropylene glycol foamable vehicle and pharmaceutical compositions thereof
US20110178162A1 (en) * 2005-10-14 2011-07-21 Medical University Of South Carolina Targeting pax2 for the induction of defb1-mediated tumor immunity and cancer therapy
US20090175799A1 (en) * 2006-09-08 2009-07-09 Dov Tamarkin Colored or colorable topical composition foam
US20080166303A1 (en) * 2006-09-08 2008-07-10 Dov Tamarkin Colored or colorable foamable composition and foam
US9682021B2 (en) 2006-11-14 2017-06-20 Foamix Pharmaceuticals Ltd. Substantially non-aqueous foamable petrolatum based pharmaceutical and cosmetic compositions and their uses
US20080260655A1 (en) * 2006-11-14 2008-10-23 Dov Tamarkin Substantially non-aqueous foamable petrolatum based pharmaceutical and cosmetic compositions and their uses
US20100221195A1 (en) * 2006-11-14 2010-09-02 Foamix Ltd. Substantially non-aqueous foamable petrolatum based pharmaceutical and cosmetic compositions and their uses
US8795635B2 (en) 2006-11-14 2014-08-05 Foamix Ltd. Substantially non-aqueous foamable petrolatum based pharmaceutical and cosmetic compositions and their uses
US20080206155A1 (en) * 2006-11-14 2008-08-28 Foamix Ltd. Stable non-alcoholic foamable pharmaceutical emulsion compositions with an unctuous emollient and their uses
US20110097279A1 (en) * 2006-11-14 2011-04-28 Foamix Ltd. Stable non-alcoholic foamable pharmaceutical emulsion compositions with an unctuous emollient and their uses
US20080292560A1 (en) * 2007-01-12 2008-11-27 Dov Tamarkin Silicone in glycol pharmaceutical and cosmetic compositions with accommodating agent
US10369102B2 (en) 2007-08-07 2019-08-06 Foamix Pharmaceuticals Ltd. Wax foamable vehicle and pharmaceutical compositions thereof
US9662298B2 (en) 2007-08-07 2017-05-30 Foamix Pharmaceuticals Ltd. Wax foamable vehicle and pharmaceutical compositions thereof
US8636982B2 (en) 2007-08-07 2014-01-28 Foamix Ltd. Wax foamable vehicle and pharmaceutical compositions thereof
US11103454B2 (en) 2007-08-07 2021-08-31 Vyne Therapeutics Inc. Wax foamable vehicle and pharmaceutical compositions thereof
US20090130029A1 (en) * 2007-11-21 2009-05-21 Foamix Ltd. Glycerol ethers vehicle and pharmaceutical compositions thereof
US9439857B2 (en) 2007-11-30 2016-09-13 Foamix Pharmaceuticals Ltd. Foam containing benzoyl peroxide
US20110045037A1 (en) * 2007-11-30 2011-02-24 Foamix Ltd. Foam containing benzoyl peroxide
US20100310476A1 (en) * 2007-12-07 2010-12-09 Foamix Ltd. Carriers, formulations, methods for formulating unstable active agents for external application and uses thereof
US8343945B2 (en) 2007-12-07 2013-01-01 Foamix Ltd. Carriers, formulations, methods for formulating unstable active agents for external application and uses thereof
US20110212033A1 (en) * 2007-12-07 2011-09-01 Foamix Ltd. Oil and liquid silicone foamable carriers and formulations
US9549898B2 (en) 2007-12-07 2017-01-24 Foamix Pharmaceuticals Ltd. Oil and liquid silicone foamable carriers and formulations
US8900553B2 (en) 2007-12-07 2014-12-02 Foamix Pharmaceuticals Ltd. Oil and liquid silicone foamable carriers and formulations
US11433025B2 (en) 2007-12-07 2022-09-06 Vyne Therapeutics Inc. Oil foamable carriers and formulations
US9161916B2 (en) 2007-12-07 2015-10-20 Foamix Pharmaceuticals Ltd. Carriers, formulations, methods for formulating unstable active agents for external application and uses thereof
US9795564B2 (en) 2007-12-07 2017-10-24 Foamix Pharmaceuticals Ltd. Oil-based foamable carriers and formulations
US8518376B2 (en) 2007-12-07 2013-08-27 Foamix Ltd. Oil-based foamable carriers and formulations
US20110008266A1 (en) * 2008-01-14 2011-01-13 Foamix Ltd. Poloxamer foamable pharmaceutical compositions with active agents and/or therapeutic cells and uses
US8709385B2 (en) 2008-01-14 2014-04-29 Foamix Ltd. Poloxamer foamable pharmaceutical compositions with active agents and/or therapeutic cells and uses
US9884017B2 (en) 2009-04-28 2018-02-06 Foamix Pharmaceuticals Ltd. Foamable vehicles and pharmaceutical compositions comprising aprotic polar solvents and uses thereof
US10588858B2 (en) 2009-04-28 2020-03-17 Foamix Pharmaceuticals Ltd. Foamable vehicles and pharmaceutical compositions comprising aprotic polar solvents and uses thereof
US10363216B2 (en) 2009-04-28 2019-07-30 Foamix Pharmaceuticals Ltd. Foamable vehicles and pharmaceutical compositions comprising aprotic polar solvents and uses thereof
US10213384B2 (en) 2009-04-28 2019-02-26 Foamix Pharmaceuticals Ltd. Foamable vehicles and pharmaceutical compositions comprising aprotic polar solvents and uses thereof
US9167813B2 (en) 2009-07-29 2015-10-27 Foamix Pharmaceuticals Ltd. Non surfactant hydro-alcoholic foamable compositions, breakable foams and their uses
US9572775B2 (en) 2009-07-29 2017-02-21 Foamix Pharmaceuticals Ltd. Non surfactant hydro-alcoholic foamable compositions, breakable foams and their uses
US10350166B2 (en) 2009-07-29 2019-07-16 Foamix Pharmaceuticals Ltd. Non surface active agent non polymeric agent hydro-alcoholic foamable compositions, breakable foams and their uses
US10092588B2 (en) 2009-07-29 2018-10-09 Foamix Pharmaceuticals Ltd. Foamable compositions, breakable foams and their uses
US11219631B2 (en) 2009-07-29 2022-01-11 Vyne Pharmaceuticals Inc. Foamable compositions, breakable foams and their uses
US9072667B2 (en) 2009-07-29 2015-07-07 Foamix Pharmaceuticals Ltd. Non surface active agent non polymeric agent hydro-alcoholic foamable compositions, breakable foams and their uses
US10137200B2 (en) 2009-10-02 2018-11-27 Foamix Pharmaceuticals Ltd. Surfactant-free water-free foamable compositions, breakable foams and gels and their uses
US9675700B2 (en) 2009-10-02 2017-06-13 Foamix Pharmaceuticals Ltd. Topical tetracycline compositions
US10265404B2 (en) 2009-10-02 2019-04-23 Foamix Pharmaceuticals Ltd. Compositions, gels and foams with rheology modulators and uses thereof
US10322186B2 (en) 2009-10-02 2019-06-18 Foamix Pharmaceuticals Ltd. Topical tetracycline compositions
US10213512B2 (en) 2009-10-02 2019-02-26 Foamix Pharmaceuticals Ltd. Topical tetracycline compositions
US10086080B2 (en) 2009-10-02 2018-10-02 Foamix Pharmaceuticals Ltd. Topical tetracycline compositions
US10029013B2 (en) 2009-10-02 2018-07-24 Foamix Pharmaceuticals Ltd. Surfactant-free, water-free formable composition and breakable foams and their uses
US9849142B2 (en) 2009-10-02 2017-12-26 Foamix Pharmaceuticals Ltd. Methods for accelerated return of skin integrity and for the treatment of impetigo
US8992896B2 (en) 2009-10-02 2015-03-31 Foamix Pharmaceuticals Ltd. Topical tetracycline compositions
US10463742B2 (en) 2009-10-02 2019-11-05 Foamix Pharmaceuticals Ltd. Topical tetracycline compositions
US10517882B2 (en) 2009-10-02 2019-12-31 Foamix Pharmaceuticals Ltd. Method for healing of an infected acne lesion without scarring
US10238746B2 (en) 2009-10-02 2019-03-26 Foamix Pharmaceuticals Ltd Surfactant-free water-free foamable compositions, breakable foams and gels and their uses
US10610599B2 (en) 2009-10-02 2020-04-07 Foamix Pharmaceuticals Ltd. Topical tetracycline compositions
US8618081B2 (en) 2009-10-02 2013-12-31 Foamix Ltd. Compositions, gels and foams with rheology modulators and uses thereof
US10821187B2 (en) 2009-10-02 2020-11-03 Foamix Pharmaceuticals Ltd. Compositions, gels and foams with rheology modulators and uses thereof
US10835613B2 (en) 2009-10-02 2020-11-17 Foamix Pharmaceuticals Ltd. Compositions, gels and foams with rheology modulators and uses thereof
US8945516B2 (en) 2009-10-02 2015-02-03 Foamix Pharmaceuticals Ltd. Surfactant-free water-free foamable compositions, breakable foams and gels and their uses
US10946101B2 (en) 2009-10-02 2021-03-16 Vyne Therapeutics Inc. Surfactant-free water-free foamable compositions, breakable foams and gels and their uses
US10967063B2 (en) 2009-10-02 2021-04-06 Vyne Therapeutics Inc. Surfactant-free, water-free formable composition and breakable foams and their uses
US8865139B1 (en) 2009-10-02 2014-10-21 Foamix Pharmaceuticals Ltd. Topical tetracycline compositions
US8871184B2 (en) 2009-10-02 2014-10-28 Foamix Ltd. Topical tetracycline compositions
US10849847B2 (en) 2016-09-08 2020-12-01 Foamix Pharamaceuticals Ltd. Compositions and methods for treating rosacea and acne
US11324691B2 (en) 2016-09-08 2022-05-10 Journey Medical Corporation Compositions and methods for treating rosacea and acne
US10398641B2 (en) 2016-09-08 2019-09-03 Foamix Pharmaceuticals Ltd. Compositions and methods for treating rosacea and acne

Similar Documents

Publication Publication Date Title
US2586287A (en) Aluminum sulfamate antiperspirant preparation
US2854382A (en) Zirconyl hydroxy chloride antiperspirant compositions
US3548056A (en) Skin protecting composition containing a water - soluble partially degraded protein
US3822312A (en) Creamy rinsing agent composition
US2309722A (en) Toilet preparation
US2814584A (en) Buffered antiperspirant compositions
US3957065A (en) Agents for permanent waving of human hair containing keratein and process for using the same
US4143159A (en) Skin-care agents containing hydroxyalkyl carboxamides and process
US2586288A (en) Aluminum sulfamate antiperspirant
US2416052A (en) Stabilized soap
US3542919A (en) Astringent alkali metal aluminum complexes of hydroxy acids
KR930010546B1 (en) Cosmetics
US3325367A (en) Antiperspirant composition
GB699196A (en) Improvements in or relating to compositions suitable for use in the manufacture of shoes
US4153726A (en) Skin protection agents containing polyethercarboxylic acids
JPH0450286B2 (en)
US2310687A (en) Hair treating composition
CA1046415A (en) Skin treating agent composition containing polyhydroxyalkylamine and process
US2889253A (en) Zirconium containing anti-perspirant compositions
US3018223A (en) Aluminum dihydroxy-titanium dilactate antiperspirant
US1979385A (en) Cosmetic preparation
JPS63156711A (en) Hair cosmetic
US2412535A (en) Antiperspirant preparation
US3833721A (en) Astringent compositions
US2586289A (en) Zinc sulfamate antiperspirant